Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Molecular Partners AG - American Depositary Shares
(NQ:
MOLN
)
3.710
UNCHANGED
Streaming Delayed Price
Updated: 3:36 PM EDT, Oct 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Molecular Partners AG - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
Looking Into Molecular Partners's Recent Short Interest
September 03, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 26, 2025
Via
Benzinga
EHang, Molecular Partners And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
August 26, 2025
Via
Benzinga
Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
August 26, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 25, 2025
Via
Benzinga
Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025
August 25, 2025
From
Molecular Partners
Via
GlobeNewswire
Earnings Scheduled For August 25, 2025
August 25, 2025
Via
Benzinga
Molecular Partners appoints Martin Steegmaier as Chief Scientific Officer to drive discovery of next-gen DARPin therapeutics
August 21, 2025
From
Molecular Partners
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
July 25, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 22, 2025
Via
Benzinga
Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025
June 22, 2025
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025
June 11, 2025
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Announces Planned Operational Efficiencies and Extension of Cash Runway
June 10, 2025
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners to Present at Upcoming Investor Conferences
May 19, 2025
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Reports Financial Results and Highlights from Q1 2025
May 15, 2025
From
Molecular Partners
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
April 25, 2025
Via
Benzinga
Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025
April 25, 2025
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Announces all Board Proposals Approved at Annual General Meeting
April 16, 2025
From
Molecular Partners
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 08, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 07, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 28, 2025
Via
Benzinga
Molecular Partners to hold three poster presentations at AACR 2025
March 25, 2025
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Publishes Invitation to Annual General Meeting 2025
March 25, 2025
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024
March 06, 2025
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Announces Participation at Upcoming Investor Conferences and 2024 Financial Results Conference Call
February 28, 2025
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners and Orano Med expand partnership to develop Targeted Alpha Radio-Therapies for cancer
January 12, 2025
From
Molecular Partners
Via
GlobeNewswire
Earnings Scheduled For March 6, 2025
March 06, 2025
Via
Benzinga
Molecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma Strategic Focus for 2025 at 43rd Annual J.P. Morgan Healthcare Conference
January 12, 2025
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January
December 17, 2024
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study and Preclinical Data on Next-Gen Conditioning Agent MP0621 at ASH 2024
December 08, 2024
From
Molecular Partners
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.